Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Pharmacogenomics|March 30, 2017
Replicated evidence for aminoacylase 3 and nephrin gene variations to predict antihypertensive drug responsesJenni M Rimpelä, Kimmo K Kontula, Frej Fyhrquist, et al.
American Journal of Hypertension|February 28, 2007
Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study)Timo P Hiltunen, Timo Suonsyrjä, Tuula Hannila-Handelberg, et al.
Annals of Medicine|July 9, 2008
Short-term electrophysiological effects of losartan, bisoprolol, amlodipine, and hydrochlorothiazide in hypertensive menKimmo Porthan, Matti Viitasalo, Timo P Hiltunen, et al.
BMC Medical Genetics|July 6, 2018
Genome-wide association study of nocturnal blood pressure dipping in hypertensive patientsJenni M Rimpelä, Ilkka H Pörsti, Antti Jula, et al.
Journal of the American Heart Association|January 28, 2015
Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugsTimo P Hiltunen, Kati M Donner, Antti-Pekka Sarin, et al.
Journal of the American Heart Association|August 20, 2019
Genome-Wide Meta-Analysis of Blood Pressure Response to β1-Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies)Sonal Singh, Helen R Warren, Timo P Hiltunen, et al.
Hypertension (Dallas, Tex. : 1979)|November 2, 2016
Genome-Wide and Gene-Based Meta-Analyses Identify Novel Loci Influencing Blood Pressure Response to HydrochlorothiazideErika Salvi, Zhiying Wang, Federica Rizzi, et al.
Journal of Hypertension|October 2, 2015
PTPRD gene associated with blood pressure response to atenolol and resistant hypertensionYan Gong, Caitrin W McDonough, Amber L Beitelshees, et al.
Pageof 4